Advanced search×

Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum.

Audio, Transactions of the IRE Professiona... 92(4):483-7 (2008) PMID 18369065

To investigate the efficacy of intravitreal bevacizumab injections for treating choroidal neovascularisation (CNV) secondary to pseudoxanthoma elasticum (PXE).

DOI: 10.1136/bjo.2007.129916
Version: za2963e q8zaf q8zb5 q8zc8 q8zdb q8ze0 q8zf4 q8zg5

Similar articles you may find interesting…

  1. INTRAVITREAL BEVACIZUMAB FOR JUXTAFOVEAL CHOROIDAL NEOVASCULARIZATION SECONDARY TO MULTIFOCAL CHOROIDITIS

    Retina 33(5):953-956 (2013) PMID 23503338

    : Mean best-corrected visual acuity changed from 0.41 logarithm of the minimum angle of resolution (approximately corresponding to 20/51 Snellen equivalent), at baseline, to 0.16 ± 0.13 logarithm of the minimum angle of resolution (approximately corresponding to 20/28 Snellen equivalent), at the 12-...
  2. VITRECTOMY COMBINED WITH PERIOCULAR/INTRAVITREAL INJECTION OF STEROIDS FOR RHEGMATOGENOUS RETINAL DETACHMENT ASSOCIATED WITH CHOROIDAL DETAC...

    Retina (2013) PMID 23648998

    : There was no significant difference in retinal reattachment rate between eyes in Group A and eyes in Group B (77.4% vs. 73.9%, P = 0.726). The retinal reattachment rates were 83.3% in Group A1, 69.2% in Group A2, 82.4% in Group B1, 73.3% in Group B2, and 64.3% in Group B3. There was no statistical...
  3. Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema.

    Ophthalmology (2013) PMID 23642372

    Compared with L, the incremental cost-effectiveness of L+R and L+B was $89 903/QALY and $11 138/QALY, respectively. L+T was dominated by L. A probabilistic sensitivity analysis demonstrated that, at a willingness to pay (WTP) of $50 000/QALY, L was approximately 70% likely to be the preferred...